Healthcare provider profile · identity verified

Manuel Vista, MD

Internal Medicine · BRONX, NY · NPI 1285120113

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	877	268
Amlodipine Besylate	Amlodipine Besylate	458	139
Albuterol Sulfate Hfa	Albuterol Sulfate	346	64
Metformin Hcl	Metformin Hcl	335	95
Lisinopril	Lisinopril	252	71
Diclofenac Sodium	Diclofenac Sodium	230	83
Losartan Potassium	Losartan Potassium	218	70
Hydrochlorothiazide	Hydrochlorothiazide	213	67
Metoprolol Succinate	Metoprolol Succinate	210	70
Gabapentin	Gabapentin	207	63
Nifedipine Er	Nifedipine	199	64
Omeprazole	Omeprazole	187	57
Levothyroxine Sodium	Levothyroxine Sodium	175	52
Simvastatin	Simvastatin	171	46
Ammonium Lactate	Ammonium Lactate	169	33
Pantoprazole Sodium	Pantoprazole Sodium	169	64
Mounjaro	Tirzepatide	166	26
Eliquis	Apixaban	150	32
Tamsulosin Hcl	Tamsulosin Hcl	142	36
Rosuvastatin Calcium	Rosuvastatin Calcium	141	49
Jardiance	Empagliflozin	134	30
Famotidine	Famotidine	132	55
Meclizine Hcl	Meclizine Hcl	132	41
Alendronate Sodium	Alendronate Sodium	125	42
Fluticasone Propionate	Fluticasone Propionate	122	28
Furosemide	Furosemide	111	44
Azelastine Hcl	Azelastine Hcl	110	30
Montelukast Sodium	Montelukast Sodium	106	37
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	103	16
Zolpidem Tartrate	Zolpidem Tartrate	98	20
Trazodone Hcl	Trazodone Hcl	97	27
Atenolol	Atenolol	90	29
Metoprolol Tartrate	Metoprolol Tartrate	89	24
Triamcinolone Acetonide	Triamcinolone Acetonide	88	34
Ozempic	Semaglutide	87	20
Glipizide Er	Glipizide	85	26
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	85	31
Ibuprofen	Ibuprofen	84	35
Meloxicam	Meloxicam	84	42
Clopidogrel	Clopidogrel Bisulfate	80	21
Chlorhexidine Gluconate	Chlorhexidine Gluconate	79	41
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	79	19
Prednisone	Prednisone	73	35
Pioglitazone Hcl	Pioglitazone Hcl	72	16
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	71	28
Valsartan	Valsartan	70	19
Januvia	Sitagliptin Phosphate	68	16
Tizanidine Hcl	Tizanidine Hcl	68	15
Carvedilol	Carvedilol	67	20
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	67	23
Metformin Hcl Er	Metformin Hcl	65	24
Ezetimibe	Ezetimibe	60	22
Tramadol Hcl	Tramadol Hcl	60	24
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	60	15
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	59	17
Hydroxyzine Hcl	Hydroxyzine Hcl	58	21
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	56	20
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	55	25
Naproxen	Naproxen	54	25
Linzess	Linaclotide	51	suppressed
Allopurinol	Allopurinol	50	14
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	50	14
Hydralazine Hcl	Hydralazine Hcl	44	13
Janumet	Sitagliptin Phos/Metformin Hcl	44	suppressed
Mirtazapine	Mirtazapine	43	13
Trulicity	Dulaglutide	39	suppressed
Fluocinonide	Fluocinonide	38	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	37	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	36	suppressed
Pravastatin Sodium	Pravastatin Sodium	35	12
Dulera	Mometasone/Formoterol	33	suppressed
Finasteride	Finasteride	33	12
Lidocaine	Lidocaine	32	12
Doxepin Hcl	Doxepin Hcl	31	12
Lactulose	Lactulose	31	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	30	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	30	11
Alcohol Prep Pads	Alcohol Antiseptic Pads	29	16
Mupirocin	Mupirocin	29	suppressed
Clindamycin Phosphate	Clindamycin Phosphate	28	suppressed
Chlorthalidone	Chlorthalidone	27	suppressed
Halobetasol Propionate	Halobetasol Propionate	27	suppressed
Propranolol Hcl	Propranolol Hcl	27	suppressed
Symbicort	Budesonide/Formoterol Fumarate	26	19
Tresiba Flextouch U-200	Insulin Degludec	26	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	25	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	25	13
Farxiga	Dapagliflozin Propanediol	24	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	24	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	24	suppressed
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	23	suppressed
Estradiol	Estradiol	23	suppressed
Sertraline Hcl	Sertraline Hcl	23	suppressed
True Comfort Pro Alcohol Pads	Alcohol Antiseptic Pads	23	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	22	suppressed
Baclofen	Baclofen	22	suppressed
Buspirone Hcl	Buspirone Hcl	22	suppressed
Ibu	Ibuprofen	21	suppressed
Nystatin	Nystatin	21	suppressed
Warfarin Sodium	Warfarin Sodium	21	suppressed
Levetiracetam	Levetiracetam	20	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	20	16
Clotrimazole	Clotrimazole	19	suppressed
Ketoconazole	Ketoconazole	19	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	19	14
Synthroid	Levothyroxine Sodium	19	suppressed
Breo Ellipta	Fluticasone/Vilanterol	18	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	18	13
Esomeprazole Magnesium	Esomeprazole Magnesium	18	suppressed
Lovastatin	Lovastatin	18	suppressed
Novolog Flexpen	Insulin Aspart	18	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	17	suppressed
Duloxetine Hcl	Duloxetine Hcl	17	suppressed
Enalapril Maleate	Enalapril Maleate	17	suppressed
Spironolactone	Spironolactone	17	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	17	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	17	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	suppressed
Ciclopirox	Ciclopirox	16	suppressed
Entresto	Sacubitril/Valsartan	16	suppressed
Incruse Ellipta	Umeclidinium Bromide	16	suppressed
Methylprednisolone	Methylprednisolone	16	16
Venlafaxine Hcl	Venlafaxine Hcl	16	suppressed
Ventolin Hfa	Albuterol Sulfate	16	suppressed
Clobetasol Propionate	Clobetasol Propionate	15	suppressed
Epinephrine	Epinephrine	15	suppressed
Fosinopril Sodium	Fosinopril Sodium	15	suppressed
Latanoprost	Latanoprost	15	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	15	suppressed
Procto-Med Hc	Hydrocortisone	15	suppressed
Victoza 3-Pak	Liraglutide	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Benazepril Hcl	Benazepril Hcl	14	suppressed
Colchicine	Colchicine	14	suppressed
Hydrocortisone	Hydrocortisone	14	suppressed
Olmesartan-Amlodipine-Hctz	Olmesartan/Amlodipin/Hcthiazid	14	suppressed
Risperidone	Risperidone	14	suppressed
Rybelsus	Semaglutide	14	suppressed
Single Use Swab	Alcohol Antiseptic Pads	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	13	suppressed
Lidocaine Hcl Viscous	Lidocaine Hcl	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	12
Potassium Chloride	Potassium Chloride	13	suppressed
Verapamil Er	Verapamil Hcl	13	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	13	suppressed
Alprazolam	Alprazolam	12	suppressed
Aspirin-Dipyridamole Er	Aspirin/Dipyridamole	12	suppressed
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	12	suppressed
Clonazepam	Clonazepam	12	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	12	suppressed
Glatopa	Glatiramer Acetate	12	suppressed
Metronidazole	Metronidazole	12	suppressed
Oxycontin	Oxycodone Hcl	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Labetalol Hcl	Labetalol Hcl	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Pregabalin	Pregabalin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error